← Open Payments lookup

AJINDER DHATT: Open Payments

NPI 1851597793 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$803 in 39 payments from 9 companies in 2025. Trend: 2023 $407 · 2024 $749 · 2025 $803

Food & beverage: $803
CompanyPaymentsAmount
ABBVIE INC.21$319
Axsome Therapeutics, Inc.2$137
Otsuka America Pharmaceutical, Inc.4$87
E.R. Squibb & Sons, L.L.C.3$74
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$65
Vanda Pharmaceuticals Inc.2$40
Supernus Pharmaceuticals, Inc.2$37
Teva Pharmaceuticals USA, Inc.1$25
Collegium Pharmaceutical, Inc.1$20

Products named: VRAYLAR, Auvelity, COBENFY, REXULTI, CAPLYTA, FANAPT, Qelbree, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.